Overweight & Obesity

Semaglutide reduces excess body fat in people with obesity

In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored ...

Diseases, Conditions, Syndromes

US halts trials of plasma transfusions for COVID patients

US health experts said Tuesday they are halting clinical trials of convalescent blood plasma in patients with mild to moderate COVID symptoms after preliminary results showed no benefit from the treatment.

page 17 from 40